prefibrotic primary myelofibrosis prepmf rare blood cancer classified world health organization distinct type myeloproliferative neoplasm disease progressive overt primary myelofibrosis though rate progression variable patients progress symptoms presentation mimic essential thrombocythemia main differentiator prepmf presence fibrosis bone marrow bone marrow examination required diagnosis bone marrow histology demonstrate according least one minor criteria reticulin collagen fibrosis grade diagnostic criteria primary myelofibrosis prepmf essential thrombocythemia share diagnostic similarities proliferation megakaryocytes presence mutation presence reticulin fibrosis prepmf provides clearest distinction two patients considered low risk thrombosis major bleeding observed lowdose aspirin recommended patients without history thrombosis intermediate risk patients symptom driven therapy anaemia constitutional symptomscitation needed high risk patients history thrombosis oral anticoagulants cytoreductive drugs hydroxycarbamide recommended patient treated primary prognosis prepmf currently suffers lack multicenter data several biases resulting disease newly distinct whos reclassification year cumulative incidence progression overt pmf year incidence transformation acute myeloid leukemia ranges prognostic scoring model designed specifically prepmf yet exist international prognostic scoring system used predict survival prepmf multicenter study reclassified pmf patients showed median survival prepmf patients years compared years overt pmf however another study showed prepmf patients alive years diagnosis overt pmf patients showed median survival years prepmf median survival able calculated patients still alive time first described prepmf introduced whos classification tumors formally classified distinct entity httpsenwikipediaorgwikiprefibroticprimarymyelofibrosis